Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participants with RA for greater than or equal to (\>/=6) months receiving 162 mg tocilizumab PFS-NSD for \>/=8 weeks and who are suitable for continued treatment at their currently prescribed dose
CGs and professionally qualified HCPs who are able and willing to administer the injection
You may not be if
RA: Functional status Class IV
RA: Neuropathies or other conditions that might interfere with pain evaluation
RA: Pregnant or breastfeeding
RA: Low neutrophil or platelet count at last laboratory assessment
RA: Elevated liver enzymes at last laboratory assessment
Current participation in another interventional clinical trial
Criteria that might give the participant/CG/HCP an advantage in injection tasks such as employment in the pharmaceutical industry, etc.
